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Activated B cells proliferate and differentiate into antibody-producing cells, long-lived
plasma cells, and memory B cells after immunization or infection. Repeated encounter
of the same antigen triggers the rapid re-activation of pre-existing speciﬁc memory B cells,
which then potentially enter new germinal center reactions and differentiate into short-lived
plasmablasts or remain in the system as memory B cells. Short-lived class-switched IgG
and IgA plasmablasts appear in the circulation transiently and the frequency of these cells
can be remarkably high. The speciﬁcities and afﬁnities of single plasmablasts in humans
have been reported for several viral infections, so far most extensively for inﬂuenza and HIV.
In general, the immunoglobulin variable regions of plasmablasts are highly mutated and
diverse, suggesting that plasmablasts are derived from memory B cells, yet it is unclear
which memory B cell subsets are activated and whether activated memory B cells adapt or
mature before differentiation.This review summarizes what is known about the phenotype
and the origin of human plasmablasts in the context of viral infections and whether these
cells can be predictors of long-lived immunity.
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PHENOTYPE OF INFECTION-INDUCED HUMAN
PLASMABLASTS IN THE BLOOD
Several studies have analyzed the kinetics and phenotypic changes
of B cells in the blood of vaccinated or infected individuals by
ﬂow cytometry. Differentiation into plasmablasts (PB) is most
commonly monitored with surface markers CD19, CD20, CD27,
CD38, and CD138 and intracellular marker Ki-67 (Table 1). CD38
catalyzes the formation of cyclic ADP–ribose and NADP and reg-
ulates Ca+ signals in lymphoid cell (Partida-Sanchez et al., 2001).
CD27, a member of the TNF receptor family that induces differ-
entiation and promotes survival (Borst et al., 2005), is expressed
on the majority of memory B cells (Wu et al., 2011) and is
highly up-regulated on plasmablasts (Qian et al., 2010). CD20
is down-regulated when blood-derived memory B cells differen-
tiate into plasmablasts (Jego et al., 2001). Plasmablasts proliferate
extensively, evident by the intracellular expression of proliferation-
associated protein Ki-67 (its function is unclear; Wrammert et al.,
2008; Qian et al., 2010). When human PBMC are differentiated
in vitro with IL-6, syndecan-1 (CD138) is acquired as a marker of
plasma cells (PC; Jego et al., 2001). This is similar in mouse studies
where CD138 is generally used as a PC marker (MacLennan et al.,
2003). However, the distinction between PB and PCs in human
blood based on CD138 is not obvious. CD138+ plasmablasts
proliferate and express CD27 and CD38 at similar levels to
CD138− plasmablasts. Interestingly, both plasmablast subsets are
induced similarly after vaccination with tetanus-, hepatitis A/B-,
or inﬂuenza-vaccine (Qian et al., 2010). The CD27highCD19low PB
population in peripheral blood contains subsets with high or low
expression of cell proliferation-associated proteins (Yoshida et al.,
2010), and CD138+ cells might represent re-circulating secondary
lymphoid organs-derived PCs, or PB in an end-differentiation
stage destined to become secondary lymphoid organ-resident PCs.
Because of the diffuse transition from the CD138− to the CD138+
phenotype most studies do not differentiate between the two
populations of cells and use the term antibody-secreting cells
(ASC; Wrammert et al., 2008, 2012; He et al., 2011; Lee et al.,
2011). The term acute plasmablasts will be used here to associate
the CD19lowCD20−CD27highCD38highCD138+/− cells appearing
after infection with the acute phase of the immune response and to
differentiate them fromsteady-state plasmablasts (Mei et al.,2009),
although any potential functional or phenotypical differences have
not been studied so far.
TIMING OF PLASMABLAST APPEARANCE IN THE BLOOD
The timing of acute PB appearance in the blood is strikingly
consistent after immunization or infection: Flow cytometry analy-
sis or ELISPOT performed ex vivo with human PBMCs sampled
daily after vaccination with attenuated yellow fever strain YF-17D
(Querec et al., 2009), inactivated inﬂuenza vaccine (Cox et al.,
1994; Moldoveanu et al., 1995; Wrammert et al., 2008; Halliley
et al., 2010; He et al., 2011), tetanus vaccine (Odendahl et al., 2005;
Qian et al., 2010), and after infection with Respiratory Syncytial
Virus (Lee et al., 2011) or dengue virus (Balakrishnan et al., 2011;
Wrammert et al., 2012) showed that plasmablast numbers peak
consistently at day 6 or 7. The response thus seems to be indepen-
dent of the adjuvant used and independent of the route of immu-
nization. The appearance of PB in the blood is transient after vacci-
nation (Odendahl et al.,2005;Lee et al.,2011)whereas theduration
of the response depends on the persistence of the virus after nat-
ural infection. After infection with acute viruses such as inﬂuenza
or dengue the PB numbers drop to baseline level within 2–3weeks
after the onset of disease (Balakrishnan et al., 2011; Wrammert
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Table 1 | Markers of infection-induced plasmablasts and plasma cells in human blood.
Marker Function Memory B cells Plasmablasts Plasma cells Reference
CD19 Transmembrane signaling molecule; part of
BCR complex; regulating BCR signal
+ Low Low Engel et al. (1995), Mei et al. (2007), Jacobi
et al. (2010)
CD20 Transmembrane signaling molecule; part of
the BCR complex
+ − − Arpin et al. (1997), Jacobi et al. (2010),
Kuijpers et al. (2010)
CD27 TNF receptor family + ++ +++ Borst et al. (2005), Mei et al. (2007), Jacobi
et al. (2010)
CD38 Signaling molecule and enzyme that cat-
alyzes the formation of cyclic ADP–ribose
+/− ++ +++ Partida-Sanchez et al. (2001), Mei et al.
(2007)
CD138 Heparan sulfate proteoglycan; syndecan-1 − +/− + Qian et al. (2010)
Ki-67 Protein expressed intracellularly during cell
division
− + +/− Wrammert et al. (2008), Qian et al. (2010),
Yoshida et al. (2010)
et al., 2012). Data from RSV-infected patients suggest that circu-
lating PBs are produced as long as the virus is actively shed from
infected cells (Lee et al., 2010). In contrast to the predictable time
of appearance, mechanisms that determine the magnitude of the
response seem to be more difﬁcult to deﬁne: Data from vaccinees
and from patients with natural viral infections show a huge vari-
ability in acute PB numbers between individuals, suggesting that
the plasmablast response is governed by multiple factors.
The impact and requirement of T cell help is unclear. The acute
PB responses observed after natural viral infection may differ in
magnitude between primary and secondary infections, but the
time of PB appearance in the circulation is similar, suggesting that
pre-existing T cell help may not be required (Wrammert et al.,
2008; Querec et al., 2009; Balakrishnan et al., 2011). However, it
is difﬁcult to exclude pre-existing immunity to viruses in endemic
areas with absolute certainty, and therefore the comparison of
primary versus secondary response is complex in the context of
natural infections. In a controlled vaccination scenario,Blanchard-
Rohner et al. (2009) demonstrate that the ASC response in naïve
individuals peaks at day 10 after primary vaccination with inacti-
vated rabies vaccine, whereas an accelerated response with a peak
at day 7 is observed after booster vaccinations. Studies in mice
show that speciﬁc T cell help promotes germinal center forma-
tion after viral infection, whereas absence of speciﬁc T cell help
results in an increased extrafollicular response (Fink et al., 2007).
PB formation in vitro is T-cell independent (Lane et al., 1995) and
T cells can suppress the differentiation of memory B cell differen-
tiation into PB in a CD40L-dependent manner (Arpin et al., 1995;
Callard et al., 1995). Possibly the timing and T cell dependence
of acute PB responses depends on the nature of the antigen and
the engagement of pattern recognition receptors. In in vitro sys-
tems, TLR7 and 9 ligands are able to facilitate memory activation
directly via TLR9 signaling in human memory B cells (Good et al.,
2009) or indirectly via TLR7-mediated activation of dendritic cells
inmice (Pordes et al., 2011) and via pDC-derived IFN-I in humans
(Bekeredjian-Ding et al., 2005). It is thus possible that activation
of memory B cells by viral infection is different from activation of
memory B cells by recombinant vaccines. More studies in humans
are required though to elucidate the mechanisms involved in T
cell-dependent and -independent activation of acute PBs.
ORIGIN OF ACUTE-PHASE PLASMABLASTS
A recent study with HIV-infected persons on anti-retroviral treat-
ment who were vaccinated with H1N1 vaccine and could be
grouped into a responder and a non-responder group showed
that the PB response at day 7 was predictive for the establishment
of memory and for speciﬁc antibody titers at day 28. The study
further showed that induction of PB and memory populations
correlated with the capacity of B cells to upregulate IL-21 receptor,
which differed in the responder- and non-responder group (Pal-
likkuth et al., 2011). In a Systems Biology approach Querec et al.
(2009) found that TNFRSF17 expression in PBMCs collected at
day 7 after yellow fever vaccination had the most predictive value
for neutralizing antibody titers at day 28. Given the high expres-
sion of TNFRSF17 on PBs (Good et al., 2009) one could conclude
that the magnitude of the PB response at day 7 is predictive for
antibody titers at day 28. Given these lines of evidence that the
early PB response may be predictive for later immunity, it is cru-
cial to understand the origin(s) of plasmablasts in the context if a
given antigen and adjuvant in order to speciﬁcally generate B cell
subsets which can be triggered during repeated infection. Early
in vitro experiments with human naïve and memory B cells from
tonsils demonstrated that memory B cells differentiate faster and
more efﬁciently into plasmablasts than naïve B cells after unspe-
ciﬁc activation with CD40L and in the presence of IL-2 and IL-10
(Arpin et al., 1997). More recent studies using Ig sequencing of
single plasma blasts and memory B cells to analyze their rela-
tion in the context of tetanus vaccination indicated that a given
memory B cell precursor can give rise to plasma blasts and mem-
ory cells at the same time (Frolich et al., 2010). Other studies
employing single cell PCR to analyze human cells after inﬂuenza
infection showed that plasmablasts are more highly mutated than
memory cells (Wrammert et al., 2008, 2011), suggesting that PB
derive from memory cells that have undergone extensive selec-
tion and have possibly reached a threshold afﬁnity required for
their activation (O’Connor et al., 2006; Phan et al., 2006). Fur-
thermore, steady-state PBs in the human gut are afﬁnity matured
and selected toward poly-reactivity and speciﬁcity for commensal
bacteria (Benckert et al., 2011). All these data indicate that PBs cir-
culating in the blood at day 6–7 after infection or immunization
(acute PBs) are memory B cell-derived. The similar timing of the
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appearance of acute PBs after primary and booster immunization
at least in the context of viral infections suggests that memory B
cells can be the source of such PBs in both scenarios (Figure 1).
However, it needs to be shown which memory B cell subsets are
involved and to which extent naïve B cells participate in the acute
PB response. Inﬂuenza vaccine Fluzone, which is administered via
the intradermal route, induces both IgA- and IgG-class-switched
PB responses, while numbers of IgA-expressing cells are 10 times
lower than the ones of IgG-expressing cells (Sasaki et al., 2011).
Natural dengue infection induces speciﬁc IgA, IgG, and IgM PB
(Wrammert et al., 2012). Our own studies show a consistent
prevalence of IgA-producing cells (mean 65%) in the acute PB
population in the blood compared to only 2% IgA cells in the
memory B cell pool in a cohort of patients with febrile illness
caused by viral infections (unpublished data). Thus, a large part of
the plasmablasts circulating during acute infection possibly derive
from mucosal sites, similarly as in steady state (Mei et al., 2009).
What is observed during infection could thus be an ampliﬁcation
of the steady state, with the difference that IgG-class-switched cells
become a signiﬁcant part of the response (Sasaki et al., 2011) pos-
sibly because more non-mucosal lymphoid organs (lymph nodes)
participate in the response. During re-infection (2ry response) the
plasmablast response is dominated by IgG+ PBs because of the for-
mation of germinal centers in both non-mucosal and mucosal tis-
sues and the generation of IgG-switched memory B cells between
1ry and 2ry infection (Figure 1).
PREDICTIVE VALUE OF PLASMABLAST RESPONSES FOR
IMMUNE MEMORY
Recent systemic approaches to study immune responses after vac-
cinations in order to ﬁnd parameters that are predictive of the
long-term response have identiﬁed dominating plasma blast sig-
natures in acute-phase (day 7) PBMC arrays (Querec et al., 2009;
Nakaya et al., 2011). Natural viral infections can generate very
impressive numbers of plasmablasts in the blood, as in the case
of dengue virus infection (Balakrishnan et al., 2011; Wrammert
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FIGURE 1 | Origin of plasmablasts in steady state and during 1ry
and 2ry infections in humans. During steady state, i.e., in healthy
individuals the majority of plasmablasts in the circulation is IgA+ and
is derived from mucosal immune responses (Mei et al., 2009). During
systemic infection more IgG+ cells from non-mucosal secondary
lymphoid organs participate in the response. During repeated (2ry)
systemic infection with the same antigen a majority of the
acute-phase plasmablasts are IgG+ and derive from memory B cells,
which have undergone class-switch and afﬁnity maturation in
germinal centers.
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et al., 2012). The important question remains what this means for
protection and immune memory induction. Even though there
might be some predictive value of the acute response for later pro-
tection (Querec et al., 2009) there are unsolved questions that need
to be addressed. In the context of viral infections it is critical to
analyze the antibody response beyond day 28 and to measure pro-
tective antibody titers by functional assays and B cell memory by
ELISPOT. It is not known whether memory B cells can still provide
protection once antibody titers fall below a protective threshold.
Memory B cells might be particularly important when neutral-
izing antibody titers are insufﬁcient to provide sterile protection.
Rapid activation of memory B cells and their differentiation into
antibody-secreting PBsmight provide antibodies in quantities that
can at least partially neutralize the virus and stop further dissemi-
nation in the organism. Indeed, the 6- to 7-day lag phase between
memory B cell activation and plasma blast formation might be
important to generate a minimal number of infected cells to trig-
ger an effective T cell response, which will in turn help to boost
and maintain B cell memory.
It is still unclear whether only a subset of B cells is triggered
during an acute response or whether different B cell subsets dif-
fer in their capacity to participate in the acute PB response.
Moreover, in the context of long-lasting antibody titers in the
blood and the maintenance of memory B cells, it is not known
whether siblings of acute, short-lived PBs can become long-lived
PCs. A recent study in mice showed that memory B cell-derived
antibodies could neutralize an escape variant of West Nile virus
whereas bone marrow-derived PCs could only neutralize the orig-
inal virus (Purtha et al., 2011). Moreover, human HIV-speciﬁc
memory B cells were recently shown to derive from polyclonal
memory B cells (Liao et al., 2011). It seems thus likely that not
only naïve B cells, but also memory B cells are engaged in pri-
mary responses or in responses against virus variants. The poten-
tial capacity of relatively unspeciﬁc memory B cells to further
afﬁnity-mature and adapt may thus be important for vaccina-
tions, particularly in adults, since highly afﬁnity matured B cells
can efﬁciently differentiate into plasmablasts. More studies on the
re-engagement of memory B cells during persistent viral infec-
tions or during re-infection with acute virus variants are required
to understand the relevance and potential impact of this type of
immune response, and to assess its predictive value for immune
memory.
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